HEALTHCARE News & Analysis

The potential for weight loss drugs to impact the sleep apnea giant has weighed on the share price, though Morningstar analyst Shane Ponraj thinks...

In a week of strong earnings from health giants CSL and Cochlear, this healthcare business reported limp revenue and sales numbers but there is...

The famed investor tells Australian investors that he's raising money to invest in opportunities that he hasn't seen in a long time.

Shares in this well-known ASX20 stock have tumbled in recent weeks, but is the market selloff overdone?  

Mark LaMonica, CFA hosts Adrian Atkins (Senior Equity Analyst - covering utilities, transports and REITs including AGL Energy and Transurban) and...

Inexpensive healthcare stocks offering defensive earnings have become harder to find in recent months, but a new addition to Morningstar’s...

Women have long been underserved in the healthtech space, but is having its own term the answer to attract funding?

Commodity-linked stocks populate the top and bottom of the league table.

Australian equities remain attractive thanks to limited exposure to the rising inflation and rates gripping markets.

We maintain our view current margin pressures are mostly temporary and leave our long-term estimates broadly unchanged.